Vermylen C, Cornu G, Ferster A, Brichard B, Ninane J, Ferrant A, Zenebergh A, Maes P, Dhooge C, Benoit Y, Beguin Y, Dresse MF, Sariban E. 1998. Haematopoietic stem cell transplantation for sickle cell anaemia: The first 50 patients transplanted in Belgium. Bone Marrow Transplantation 22(1):1–6.

Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, Goldman A, Kersey J, Krivit W, MacMillan ML, Orchard PJ, Peters C, Weisdorf DJ, Ramsay NKC, Davies SM. 2002. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: Influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100(5):1611–1618.

Weinreb S, Delgado JC, Clavijo OP, Yunis EJ, Bayer-Zwirello L, Polansky L, Deluhery L, Cohn G, Yao JT, Stec TC, Higby D, Anderzejewski C. 1998. Transplantation of unrelated cord blood cells. Bone Marrow Transplantation 22(2):193–196.

Wexler SA, Donaldson C, Denning-Kendall P, Rice C, Bradley B, Hows JM. 2003. Adult bone marrow is a rich source of human mesenchymal “stem” cells but umbilical cord and mobilized adult blood are not. British Journal of Haematology 121(2):368–374.

Willenbring H, Bailey AS, Foster M, Akkari Y, Dorrell C, Olson S, Finegold M, Fleming WH, Grompe M. 2004. Myelomonocytic cells are sufficient for therapeutic cell fusion in liver. Nature Medicine 10(7):744–748.

Willing AE, Lixian J, Milliken M, Poulos S, Zigova T, Song S, Hart C, Sanchez-Ramos J, Sanberg PR. 2003. Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. Journal of Neuroscience Research 73(3):296–307.

Winkelstein JA, Winkelstein ML. 2001. The Wiskott-Aldrich syndrome. Winkelstein JA, Winkelstein ML, eds. Patient and Family Handbook for the Primary Immune Deficiency Diseases. Towson, MD: Immune Deficiency Foundation. Pp. 36–39. [Online] Available:

Yu M, Xiao Z, Shen L, Li L. 2004. Mid-trimester fetal blood-derived adherent cells share characteristics similar to mesenchymal stem cells but full-term umbilical cord blood does not. British Journal of Haematology 124(5):666–675.

Zhai QL, Qiu LG, Li Q, Meng HX, Han JL, Herzig RH, Han ZC. 2004. Short-term ex vivo expansion sustains the homing-related properties of umbilical cord blood hematopoietic stem and progenitor cells. Haematologica 89(3):265–273.

Zheng Y, Watanabe N, Nagamura-Inoue T, Igura K, Nagayama H, Tojo A, Tanosaki R, Takaue Y, Okamoto S, Takahashi TA. 2003. Ex vivo manipulation of umbilical cord blood-derived hematopoietic stem/progenitor cells with recombinant human stem cell factor can up-regulate levels of homing-essential molecules to increase their transmigratory potential. Experimental Hematology 31(12):1237–1246.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement